Bioprocessing Strategies: How to Reduce Host Cell Proteins?
•
5 min read
In biopharmaceutical manufacturing, Host Cell Proteins (HCPs) are a critical process-related impurity, with regulatory agencies often requiring levels below 100 parts per million (ppm) in the final drug product. Controlling these impurities is vital, as they can impact product stability, safety, and efficacy. This guide addresses effective strategies on how to reduce host cell proteins throughout the production process.
